Headaches, Phase I

Repeat Dosing of Psilocybin in Migraine Headache

Volunteers
Health Professionals

What is the purpose of this trial?

In seeking to understand the capacity for psilocybin to reduce migraine headache burden, this study will investigate single and repeated dosing of psilocybin up to two doses. In seeking to identify an underlying mechanism in psilocybin's effects, neuroinflammatory markers for migraine headache will be measured.

Trial with
Wallace Research Foundation
Ages
21 years - 65 years
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Mackenzie Creighton

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Emmanuelle Schindler, MD, PhD
Assistant Professor; Medical Director, Headache Center of Excellence

Sub-Investigator

Deepak Cyril Dsouza, MBBS, MD

Last Updated
12/22/2022
Study HIC
#2000026974